Improves productivity and provides enhanced clinical insights

The Sysmex XE-2100 utilizes the power of fluorescent flow cytometry and hydrodynamic focusing technologies. Using a unique laser diode table, fluorescent flow cytometry provides the sensitivity needed to measure and differentiate cell types in whole blood and body fluid samples. Fluorescent technology and hydrodynamic focusing allows the XE-2100 to consistently differentiate normal platelet, erythrocyte, and leukocyte populations from abnormal populations, thereby reducing the number of manual interventions. The XE-2100 technology provides reportable and clinically relevant parameters.

Standard

• NRBC fluorescent counting with excellent sensitivity and specificity for low review rates
• Provides improvement in low sensitivity
• Allows for quick reporting
• Provides efficient automated correction of WBC and spread results
• Immature granulocyte count (IG% and #) provides quantitative and reportable results for metamyelocytes, myelocytes, and promyelocytes
• Reduces rates of low positives and false negatives
• Achieve consistent results by reducing technician-to-technician variations in reporting manual differentials
• Improve response time with fewer manual spreads
• Platelet counts using fluorescent optical and traditional impedance technology to improve the accuracy of very high and very low platelet counts
• Get accurate counts when interference is present
• Offers automated resolution by reporting PLT-O or PLT-I through instrument adjustments
• Retic: Fluorescent reticulocyte counting to reduce manual confirmation methods and their inherent errors
• Eliminate common interference to avoid manual counts
• Improves the information of immature reticulocytes (IRF)
• Reportable WBC and RBC counts for all common body fluid samples (CSF, synovial, and serous)

Optional

• RET-He: reticulocyte hemoglobin count content measures the incorporation of iron within erythrocytes to assist the physician with the evaluation and management of anemia (e.g., anemia for functional iron deficiency)
• Provides direct and rapid analysis of an early stage of red blood cell development
• It is an established parameter used in the Medical Guidelines for the Management of Kidney Disease (KDOQI) to assess baseline iron status in this type of patient
• Supports effective adherence to protocols for expensive drugs for cell stimulation
• IPF: Immature Platelet Fraction to Help the Physician Monitor Thrombopoietic Activity of the Bone Marrow
• Ensures accuracy and sensitivity in immature platelet measurements
• Provides delineation of abnormal platelet populations observed by doctors in disease states such as autoimmune purple thrombocytopenia (AITP) or purpura thrombotic thrombocytopenia (TTP)
• Allows rapid reporting of results for prompt clinical information
• HPC: A hematopoietic progenitor cell count that can be used by the doctor to determine the presence of hematopoietic progenitor cells and umbilical cord samples
• Provides quality information to better assist clinicians with patient treatment protocols
• Offers rapid analysis versus conventional methods for rapid determination of optimal cell harvest time
• Reduces costs as the system does not require additional reagents, sample volume, or specific technical knowledge